A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

A new study from researchers at Moffitt Cancer Center shows that blocking a chemical process called nitrosylation could make ...

For patients with cancers harboring certain genetic defects, the first-in-class targeted therapy RO7589831, which targets the ...

Immune checkpoint inhibitor-based combinations have become the preferred first-line therapy for patients with metastatic clear cell renal cell carcinoma, but more than a third of eligible patients do ...